Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study.

Background The correlation between visual emphysema patterns and subsequent progression of disease may provide a way to enrich a study population for treatment trials of emphysema. Purpose To evaluate the potential relationship between emphysema visual subtypes and progression of emphysema and gas trapping. Materials and Methods Current and former smokers with and without chronic obstructive pulmonary disease (COPD) enrolled in the prospective Genetic Epidemiology of COPD (COPDGene) study (ClinicalTrials.gov identifier: NCT02445183) between 2008 and 2011 had their Fleischner Society visual CT scores assessed at baseline, quantitative inspiratory, and expiratory CT and at 5 years. They also underwent pulmonary function testing at baseline CT and at 5 years. The dependent variables were inspiratory lung density at 15th percentile (adjusted for lung volume) as a measure of emphysema and percentage of lung volume with attenuation less than -856 HU at expiratory CT as a measure of air trapping. Statistical analysis used a linear mixed model, adjusted for age, height, sex, race, smoking status, and scanner make. Results A total of 4166 participants (mean age, 60 years ± 9 [standard deviation]; 2091 [50%] men) were evaluated. In participants with COPD (1655 participants, 40%), those with visual presence of mild, moderate, and confluent emphysema at baseline CT showed a mean decline in lung density of 4.6 g/L ± 1.1 (P < .001), 6.7 g/L ± 1.1 (P < .001), and 6.4 g/L ± 1.2 (P < .001), respectively, compared with 2.4 g/L ± 1.3 (P < .001) for those with trace emphysema. For participants without COPD, those with visual presence of mild and moderate emphysema at baseline CT showed a mean decline in lung density of 3.6 g/L ± 1.0 (P < .001) and 3.1 g/L ± 1.6 (P < .001), respectively, compared with 1.8 g/L ± 1.0 (P < .001) for those with trace emphysema. Conclusion The pattern of parenchymal emphysema at baseline CT was an independent predictor of subsequent progression of emphysema in participants who are current or former cigarette smokers with and without chronic obstructive pulmonary disease. © RSNA, 2020 Online supplemental material is available for this article.

[1]  E. Regan,et al.  Five-Year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study. , 2020, Radiology.

[2]  F. Martinez,et al.  Chronic obstructive pulmonary disease subpopulations and phenotyping , 2018, Journal of Allergy and Clinical Immunology.

[3]  Edwin K Silverman,et al.  CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study , 2018, Radiology.

[4]  D. Lynch,et al.  Paratracheal Paraseptal Emphysema and Expiratory Central Airway Collapse in Smokers , 2018, Annals of the American Thoracic Society.

[5]  Eric A. Hoffman,et al.  Lobar Emphysema Distribution Is Associated With 5‐Year Radiological Disease Progression , 2018, Chest.

[6]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[7]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[8]  Meilan K. Han,et al.  Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. , 2016, American journal of respiratory and critical care medicine.

[9]  Robert Paine,et al.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.

[10]  Y. Oh,et al.  Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.

[11]  Meilan K. Han,et al.  Clinical and Radiologic Disease in Smokers With Normal Spirometry. , 2015, JAMA internal medicine.

[12]  Berend C Stoel,et al.  Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[13]  Edwin K Silverman,et al.  CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. , 2015, Radiology.

[14]  Edwin K Silverman,et al.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene , 2014, Respiratory Research.

[15]  J. Corhay,et al.  [Phenotypes in chronic obstructive pulmonary disease]. , 2014, Revue medicale de Liege.

[16]  Carla G. Wilson,et al.  Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. , 2013, AJR. American journal of roentgenology.

[17]  L. Edwards,et al.  Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort , 2013, European Respiratory Journal.

[18]  Courtney Crim,et al.  The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. , 2013, The Lancet. Respiratory medicine.

[19]  A. Bankier,et al.  Chronic obstructive pulmonary disease: CT quantification of airways disease. , 2012, Radiology.

[20]  Ciro Casanova,et al.  The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. , 2011, American journal of respiratory and critical care medicine.

[21]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[22]  M. Pistolesi,et al.  Phenotypes of chronic obstructive pulmonary disease , 2010 .

[23]  J. Gurney,et al.  Vanishing Lung Syndrome (Giant Bullous Emphysema): CT Findings in 7 Patients and a Literature Review , 2009, Journal of thoracic imaging.

[24]  Johan H C Reiber,et al.  Volume correction in computed tomography densitometry for follow-up studies on pulmonary emphysema. , 2008, Proceedings of the American Thoracic Society.

[25]  B C Stoel,et al.  Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency , 2006, Thorax.

[26]  P. Gevenois,et al.  Pulmonary emphysema: objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry. , 2006, Radiology.

[27]  N H Holstein-Rathlou,et al.  Volume adjustment of lung density by computed tomography scans in patients with emphysema , 2004, Acta radiologica.

[28]  H. Kundel,et al.  Measurement of observer agreement. , 2003, Radiology.

[29]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[30]  P. Paré,et al.  A quantification of the lung surface area in emphysema using computed tomography. , 1999, American journal of respiratory and critical care medicine.

[31]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[32]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[33]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[34]  Standardized Questionaries on Respiratory Symptoms* , 1960 .